The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity

Vaccine

Volumn 27, Issue 2, 2009, Pages 328-335

  Bongfen, Silayuv E ^a   Ntsama, Patricia M ^a   Offner, Sandra ^a   Smith, Thomas ^b   Felger, Ingrid ^b   Tanner, Marcel ^b   Alonso, Pedro ^c   Nebie, Issa ^d   Romero, Jackeline F ^a   Silvie, Olivier ^e   Torgler, Ralph ^a   Corradin, Giampietro ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c HOSPITAL CLÍNIC   (Spain)

^d Burkina Faso   (Burkina Faso)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Plasmodium berghei; Plasmodium falciparum; Synthetic peptides

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CELL INVASION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LIVER CELL; MALARIA CONTROL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; CHILD, PRESCHOOL; FEMALE; HEPATOCYTES; HUMANS; MALARIA; MALARIA VACCINES; MALARIA, FALCIPARUM; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 57249094204     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.097     Document Type: Article

References (40)

1. Nussenzweig R.S., Vanderberg J., Most H., and Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216 5111 (1967) 160-162
2. Clyde D.F. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 24 3 (1975) 397-401
3. Zavala F., Tam J.P., Hollingdale M.R., Cochrane A.H., Quakyi I., Nussenzweig R.S., et al. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228 4706 (1985) 1436-1440
4. Ballou W.R., Hoffman S.L., Sherwood J.A., Hollingdale M.R., Neva F.A., Hockmeyer W.T., et al. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1 8545 (1987) 1277-1281
5. Herrington D.A., Clyde D.F., Losonsky G., Cortesia M., Murphy J.R., Davis J., et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328 6127 (1987) 257-259
6. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282 5388 (1998) 476-480
7. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Castro Z.R., Nussenzweig R.S., Schmeckpeper B., et al. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. J Infect Dis 182 5 (2000) 1486-1496
8. Stoute J.A., Slaoui M., Heppner D.G., Momin P., Kester K.E., Desmons P., et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med 336 2 (1997) 86-91
9. Renia L., Grillot D., Marussig M., Corradin G., Miltgen F., Lambert P.H., et al. Effector functions of circumsporozoite peptide-primed CD4+T cell clones against Plasmodium yoelii liver stages. J Immunol 150 4 (1993) 1471-1478
10. Rodrigues M.M., Cordey A.S., Arreaza G., Corradin G., Romero P., Maryanski J.L., et al. CD8+cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 3 6 (1991) 579-585
11. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., and Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341 6240 (1989) 323-326
12. Tsuji M., Romero P., Nussenzweig R.S., and Zavala F. CD4+ cytolytic T cell clone confers protection against murine malaria. J Exp Med 172 5 (1990) 1353-1357
13. Weiss W.R., Berzofsky J.A., Houghten R.A., Sedegah M., Hollindale M., and Hoffman S.L. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J Immunol 149 6 (1992) 2103-2109
14. Rathore D., Nagarkatti R., Jani D., Chattopadhyay R., de la Vega P., Kumar S., et al. An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion. J Biol Chem 280 21 (2005) 20524-20529
15. Roggero M.A., Filippi B., Church P., Hoffman S.L., Blum-Tirouvanziam U., Lopez J.A., et al. Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein. Mol Immunol 32 17-18 (1995) 1301-1309
16. Roggero M.A., Meraldi V., Lopez J.A., Eberl G., Romero J.C., Matile H., et al. The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response. Eur J Immunol 30 9 (2000) 2679-2685
17. Alonso P.L., Sacarlal J., Aponte J.J., Leach A., Macete E., Milman J., et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364 9443 (2004) 1411-1420
18. Kester K.E., McKinney D.A., Tornieporth N., Ockenhouse C.F., Heppner Jr. D.G., Hall T., et al. A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults. Vaccine 25 29 (2007) 5359-5366
19. Rathore D., Sacci J.B., de la Vega P., and McCutchan T.F. Binding and invasion of liver cells by Plasmodium falciparum sporozoites. Essential involvement of the amino terminus of circumsporozoite protein. J Biol Chem 277 9 (2002) 7092-7098
20. Coppi A., Pinzon-Ortiz C., Hutter C., and Sinnis P. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J Exp Med 201 1 (2005) 27-33
21. Lopez J.A., Gonzalez J.M., Kettner A., Arevalo-Herrera M., Herrera S., Corradin G., et al. Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys. Ann Trop Med Parasitol 91 3 (1997) 253-265
22. Doolan D.L., Hoffman S.L., Southwood S., Wentworth P.A., Sidney J., Chesnut R.W., et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7 1 (1997) 97-112
23. Gonzalez J.M., Peter K., Esposito F., Nebie I., Tiercy J.M., Bonelo A., et al. HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT. Parasite Immunol 22 10 (2000) 501-514
24. Lopez J.A., Weilenman C., Audran R., Roggero M.A., Bonelo A., Tiercy J.M., et al. A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies. Eur J Immunol 31 7 (2001) 1989-1998
25. Meraldi V., Romero J.F., Kensil C., and Corradin G. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. Vaccine 23 21 (2005) 2801-2812
26. Dame J.B., Williams J.L., McCutchan T.F., Weber J.L., Wirtz R.A., Hockmeyer W.T., et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225 (1984) 593-599
27. de la Cruz V.F., Lal A.A., and McCutchan T.F. Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development. J Biol Chem 262 25 (1987) 11935-11939
28. Tewari R., Spaccapelo R., Bistoni F., Holder A.A., and Crisanti A. Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity. J Biol Chem 277 49 (2002) 47613-47618
29. Stuber D., Bannwarth W., Pink J.R., Meloen R.H., and Matile H. New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein. Eur J Immunol 20 4 (1990) 819-824
30. Mota M.M., Pradel G., Vanderberg J.P., Hafalla J.C., Frevert U., Nussenzweig R.S., et al. Migration of Plasmodium sporozoites through cells before infection. Science 291 5501 (2001) 141-144
31. Nudelman S., Renia L., Charoenvit Y., Yuan L., Miltgen F., Beaudoin R.L., et al. Dual action of anti-sporozoite antibodies in vitro. J Immunol 143 3 (1989) 996-1000
32. Jesuino B.S., Casimiro C., do Rosario V.E., and Silveira H. Effect of antibodies on the expression of Plasmodium falciparum circumsporozoite protein gene. Int J Med Sci 3 1 (2006) 7-10
33. Charoenvit Y., Leef M.F., Yuan L.F., Sedegah M., and Beaudoin R.L. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immun 55 3 (1987) 604-608
34. Alonso P.L., Lopez M.C., Bordmann G., Smith T.A., Aponte J.J., Weiss N.A., et al. Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children. Parasite Immunol 20 2 (1998) 63-71
35. Ramharter M., Winkler H., Kremsner P.G., Adegnika A.A., Willheim M., and Winkler S. Age-dependency of Plasmodium falciparum-specific and non-specific T cell cytokine responses in individuals from a malaria-endemic area. Eur Cytokine Netw 16 2 (2005) 135-143
36. Sharma S.K., Chattopadhyay R., Chakrabarti K., Pati S.S., Srivastava V.K., Tyagi P.K., et al. Epidemiology of malaria transmission and development of natural immunity in a malaria-endemic village, San Dulakudar, in Orissa state, India. Am J Trop Med Hyg 71 4 (2004) 457-465
37. Cohen S., Mc G.I., and Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 192 (1961) 733-737
38. Lopez J.A., Roggero M.A., Duombo O., Gonzalez J.M., Tolle R., Koita O., et al. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors. Am J Trop Med Hyg 55 4 (1996) 424-429
39. Doolan D.L., and Hoffman S.L. The complexity of protective immunity against liver-stage malaria. J Immunol 165 3 (2000) 1453-1462
40. Riley E.M., Wahl S., Perkins D.J., and Schofield L. Regulating immunity to malaria. Parasite Immunol 28 1-2 (2006) 35-49